CDXS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 12, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Codexis Inc (CDXS)

Based on 13 analysts giving stock ratings to Codexis Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
31
Buy
46
Hold
23
Sell
0
Strong Sell
0
Codexis Inc

Codexis Inc. Stock Analysis CDXS

United States Health Care Micro Cap Report:
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. The company is headquartered in Redwood City, California and currently employs 146 full-time employees. The company went IPO on 2010-04-22. The company is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The firm utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. The company is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The firm also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Read More

Codexis Inc (CDXS) Chart

Key Statistics of Codexis Inc (CDXS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.40$2.54

Today's Open

$2.50

Volume

773.94K

P/E Ratio (TTM)

-

52 Week Range

$0.96$3.87

Market Cap

249.89M

Avg. Volume

1.27M

Dividend Yield

-

Financial Metrics & Statements of Codexis Inc (CDXS)

FAQ's for Codexis Inc (CDXS)

  • According to Musaffa’s Shariah screening methodology, Codexis Inc (CDXS) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.